Literature DB >> 16198310

A proline-90 residue unique to SUMO-4 prevents maturation and sumoylation.

David Owerbach1, Eileen M McKay, Edward T H Yeh, Kenneth H Gabbay, Kurt M Bohren.   

Abstract

Four small ubiquitin-related modifier (SUMO) genes have been identified in humans. However, little is known about the basic biology of SUMO-4. Here, we report that SUMO-4 differs from SUMO-1, -2, and -3 in that the maturation process of SUMO-4 to active form containing C-terminal di-glycine residues is inhibited by a unique proline residue located at position 90 (Pro-90). Although, both the hydrolase and isopeptidase activities of SUMO peptidases are significantly diminished by Pro-90 as compared to Gln-90 (glutamine) in mutated SUMO genes, only the defective hydrolase activity appears to be biologically relevant. Native SUMO-4, thus, appears to be unable to form covalent isopeptide bonds with substrates. A biological role of SUMO-4, through non-covalent interactions is proposed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16198310     DOI: 10.1016/j.bbrc.2005.09.090

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  87 in total

Review 1.  Human pathogens and the host cell SUMOylation system.

Authors:  Peter Wimmer; Sabrina Schreiner; Thomas Dobner
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Isoform-specific monobody inhibitors of small ubiquitin-related modifiers engineered using structure-guided library design.

Authors:  Ryan N Gilbreth; Khue Truong; Ikenna Madu; Akiko Koide; John B Wojcik; Nan-Sheng Li; Joseph A Piccirilli; Yuan Chen; Shohei Koide
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-25       Impact factor: 11.205

3.  Small ubiquitin-like modifier (SUMO) modification mediates function of the inhibitory domains of developmental regulators FOXC1 and FOXC2.

Authors:  Theodora E Danciu; Sergey Chupreta; Osvaldo Cruz; Jennifer E Fox; Malcolm Whitman; Jorge A Iñiguez-Lluhí
Journal:  J Biol Chem       Date:  2012-04-05       Impact factor: 5.157

Review 4.  Cardiac function and disease: emerging role of small ubiquitin-related modifier.

Authors:  Jun Wang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

5.  Multiple Levels of Control Determine How E4bp4/Nfil3 Regulates NK Cell Development.

Authors:  Tomasz Kostrzewski; Aaron J Borg; Yiran Meng; Iva Filipovic; Victoria Male; Andreas Wack; Peter A DiMaggio; Hugh J M Brady
Journal:  J Immunol       Date:  2018-01-08       Impact factor: 5.422

6.  The SUMO-specific protease SENP5 is required for cell division.

Authors:  Alessandra Di Bacco; Jian Ouyang; Hsiang-Ying Lee; Andre Catic; Hidde Ploegh; Grace Gill
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

7.  Crystal structure of the SENP1 mutant C603S-SUMO complex reveals the hydrolytic mechanism of SUMO-specific protease.

Authors:  Zheng Xu; So Fun Chau; Kwok Ho Lam; Ho Yin Chan; Tzi Bun Ng; Shannon W N Au
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

8.  A novel proteomics approach to identify SUMOylated proteins and their modification sites in human cells.

Authors:  Frederic Galisson; Louiza Mahrouche; Mathieu Courcelles; Eric Bonneil; Sylvain Meloche; Mounira K Chelbi-Alix; Pierre Thibault
Journal:  Mol Cell Proteomics       Date:  2010-11-22       Impact factor: 5.911

Review 9.  SUMO: a multifaceted modifier of chromatin structure and function.

Authors:  Caelin Cubeñas-Potts; Michael J Matunis
Journal:  Dev Cell       Date:  2013-01-14       Impact factor: 12.270

10.  SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX.

Authors:  Sam R Holmstrom; Sergey Chupreta; Alex Yick-Lun So; Jorge A Iñiguez-Lluhí
Journal:  Mol Endocrinol       Date:  2008-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.